Vascular Graft Market to Top $8 Billion by 2030

Solid, steady growth is forecast for the global vascular graft market for the rest of this decade.

An Allied Market Research report estimates the market generated $4.99 billion in 2020, and projects it to reach $8.13 billion by 2030, expanding 4.9% annually through 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
 
Growth drivers for the vascular graft sector include an increase in vascular diseases such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders; an increase in the number of hospitals and surgery centers; and advancements in vascular disease devices. However, product failure and product recalls are expected to restrict the market growth. On the other hand, new product launches present new opportunities in the upcoming years. 

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the vascular grafts market as most hospitals were not operating due to COVID-19 pandemic and the ongoing lockdowns in many countries. However, a large number of clinics and hospitals worldwide were restructured to increase the hospital capacity to provide improve healthcare services, and this is expected to increase the diagnosis and surgeries of vascular diseases, which contributes in the market growth.
 
Based on product, the endovascular aneurysm repair stent grafts segment held the highest market share in 2020, holding nearly three-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the hemodialysis access graft segment is estimated to register the compound annual growth rate (CAGR) from 2021 to 2030.  
 
Based on end user, the hospitals segment held the largest market share in 2020, holding more than half of the total market share, and is expected to continue its leadership status during the forecast period. However, the ambulatory surgical centers (ASCs) segment is projected to register the highest CAGR (5%) from 2021 to 2030.
 
Based on region, Europe contributed to the highest share in terms of revenue in 2020, holding around half of the total market share, and is estimated to continue its dominant share by 2030. However, North America is projected to manifest the fastest CAGR (6.1%) during the forecast period.
 
Leading players of the global vascular graft market analyzed in the research include B. Braun Melsungen AG, Becton, Dickinson and Company, Cook Medical Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates Inc.